erlotinib hydrochloride has been researched along with aldosterone in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (aldosterone) | Trials (aldosterone) | Recent Studies (post-2010) (aldosterone) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 25,333 | 1,517 | 4,169 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | aldosterone (IC50) |
|---|---|---|---|
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0048 | |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 0.043 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, W; Gu, Y; Niu, J; Qiao, Z; Sheng, L; Yang, M; Zhang, M | 1 |
1 other study(ies) available for erlotinib hydrochloride and aldosterone
| Article | Year |
|---|---|
Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney.
Topics: Aldosterone; Animals; Cell Line; Cell Movement; Cell Proliferation; ErbB Receptors; Erlotinib Hydrochloride; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Hypertrophy; Kidney; Kidney Glomerulus; Male; MAP Kinase Signaling System; Mesangial Cells; Mice; Models, Biological; Phosphorylation; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Mineralocorticoid; Signal Transduction; Transcriptional Activation | 2016 |